Hermetica Superfood Encyclopedia
The Short Answer
Two-row barley delivers a concentrated matrix of phenolic acids (notably ferulic acid at 104–365 μg/g), β-glucans, tocols (α-tocotrienol at 17–20 μg/g), and proanthocyanidins that collectively scavenge free radicals, bind bile acids, and inhibit LDL oxidation by 19–34% at low extract concentrations. Meta-analyses of barley β-glucan intake at 3–6 g/day demonstrate LDL cholesterol reductions of 5–7%, while its superior micronutrient density—including higher fiber (6 g per serving), niacin, vitamin B6, iron, zinc, selenium, manganese, and copper compared to modern grain varieties—supports broad cardiometabolic and antioxidant health.
CategoryOther
GroupAncient Grains
Evidence LevelPreliminary
Primary Keywordtwo-row barley benefits
Two-Row Barley — botanical close-up
Health Benefits
**Cardiovascular Cholesterol Reduction**
β-Glucans (soluble fiber) bind bile acids in the gut lumen, reducing their reabsorption and driving hepatic cholesterol catabolism; meta-analyses extrapolated from general barley and oat data show 3–6 g/day lowers LDL cholesterol by approximately 5–7%.
**Antioxidant Defense**
Phenolic acids—especially bound ferulic acid (104–365 μg/g) and p-coumaric acid—along with α-tocotrienol (17–20 μg/g) neutralize reactive oxygen species (ROS) and chelate pro-oxidant metals, inhibiting Cu(II)-induced LDL oxidation by 19.64–33.93% in vitro at 0.02 mg/mL extract concentrations.
**Blood Glucose Regulation**
Viscous β-glucans slow gastric emptying and blunt postprandial glucose absorption by increasing luminal viscosity, reducing the rate of starch digestion and attenuating insulin spikes; this mechanism is consistent with established FDA-qualified health claims for barley β-glucan.
**Micronutrient Repletion**
Two-row barley provides meaningful quantities of iron, zinc, selenium, manganese, copper, niacin, and vitamin B6 in concentrations exceeding many modern refined grain varieties, supporting enzymatic cofactor availability for energy metabolism, immune function, and oxidative stress defense.
**Anti-Inflammatory Lignan Activity**
Plant lignans 7-hydroxymatairesinol (541 μg/100g) and secoisolariciresinol (28 μg/100g) are converted by gut microbiota to enterolignans (enterodiol, enterolactone), which modulate estrogenic signaling and downregulate pro-inflammatory cytokine pathways.
**Gastrointestinal Health and Microbiome Support**
High β-glucan and arabinoxylan content (aleurone layer: 60–70% arabinoxylans) serves as prebiotic substrate, selectively fermenting to short-chain fatty acids (SCFAs) that nourish colonocytes, lower luminal pH, and promote populations of beneficial Lactobacillus and Bifidobacterium species.
**Potential Antiproliferative Effects**
Proanthocyanidins—including prodelphinidin B3 (90–197 μg/g) and procyanidin C2 (5–19 μg/g)—along with phenolic extracts have demonstrated antiproliferative activity against cancer cell lines in vitro, mediated through ROS downregulation and induction of apoptotic signaling pathways, though human clinical data remain absent.
Origin & History
Natural habitat
Two-row barley (Hordeum vulgare) is one of the earliest domesticated cereal grains, originating in the Fertile Crescent of the Near East approximately 10,000 years ago and spreading throughout Europe, Asia, and North Africa. The 'two-row' designation refers to the arrangement of fertile florets along the rachis, with only two rows of grain developing per spike, in contrast to six-row varieties. It thrives in temperate climates with cool growing seasons, well-drained loamy soils, and moderate rainfall, and is commercially cultivated today in Germany, the United Kingdom, Australia, Canada, and the United States primarily for malting and brewing industries.
“Barley holds the distinction of being one of humanity's oldest cultivated cereals, with archaeobotanical evidence of cultivation dating to approximately 8500 BCE in the Levantine corridor, and two-row types appearing to precede six-row domesticates in the archaeological record of the Near East. In ancient Egypt, barley grain was integral to both bread-making and fermented beer production, with evidence from tomb inscriptions and grain stores at Amarna indicating its status as a dietary staple and ritual offering. Traditional Chinese Medicine employed barley (Da Mai) as a Qi-tonifying food to strengthen the Spleen and Stomach, relieve Summer Heat, and treat edema, while Ayurvedic practice (Yava) used barley decoctions for urinary tract complaints, fever reduction, and as a post-illness restorative. European medieval herbalists including Hildegard von Bingen referenced barley gruel as a medicinal food for convalescents, and barley water remained a standard pharmacopeial preparation in British medicine through the 19th century for febrile illness and renal complaints.”Traditional Medicine
Scientific Research
The clinical evidence base for two-row barley specifically as a supplement or extract is limited; most human intervention data derives from studies using general hulled or pearled barley fractions rather than two-row cultivar-isolated preparations, which constrains direct translational conclusions. In vitro evidence is robust: phenolic extracts at 0.02 mg/mL inhibit Cu(II)-induced LDL oxidation by 19.64–33.93%, and total phenolic content across cultivars ranges 3.21–9.73 mg GAE/g DW, with antioxidant capacity confirmed across multiple assay platforms (DPPH, ABTS, FRAP). Meta-analyses of randomized controlled trials (RCTs) examining barley β-glucan across multiple grain types and formulations—involving hundreds of participants—consistently demonstrate 5–7% reductions in LDL cholesterol at 3 g/day, supporting the FDA-qualified health claim; however, no published RCT has isolated two-row barley as a distinct intervention with pre-specified cultivar identity. Phytochemical characterization studies are well-executed and reproducible, but bioavailability studies for bound phenolics in humans are sparse, and antiproliferative findings remain exclusively preclinical with no human trial data available as of 2024.
Preparation & Dosage
Traditional preparation
**Whole Grain (Cooked)**
50–100 g dry weight per serving; retains intact β-glucan, arabinoxylan, and bound phenolic matrix; requires soaking 4–8 hours and boiling 45–60 minutes
**Pearled Barley**
40–75 g dry
Outer husk and bran partially removed; reduces antinutrients and improves palatability but decreases bound phenolic and tocol content; typical serving .
**Barley Flour**
Whole-grain or refined; incorporated into baked goods at 20–50% substitution ratio for wheat flour to preserve β-glucan content; no standardized supplement dose established.
**β-Glucan Concentrate (Extracted)**
3–6 g/day of isolated barley β-glucan (≥70% purity) is the dose supported by FDA-qualified health claim and meta-analyses for LDL reduction; taken with meals to maximize bile acid binding
**Barley Water (Traditional Decoction)**
50–100 g hulled grains simmered in 1–1
5 L water for 30–45 minutes, strained; consumed warm; historically used as a digestive tonic and fever remedy.
**Talbina (Ayurvedic/Islamic Preparation)**
Barley flour boiled in water or milk (1–2 tablespoons flour per cup liquid) to a thin porridge consistency; consumed as a nutritive tonic.
**Malt Extract**
Germinated two-row barley kiln-dried and extracted; used primarily in brewing; phytochemical profile altered by kilning temperature—higher temperatures degrade heat-labile phenolics.
**Timing Note**
β-Glucan is most effective for glycemic control when consumed as part of or immediately before a carbohydrate-containing meal to maximize viscosity in the small intestine.
Nutritional Profile
Per 100 g dry whole-grain two-row barley: approximately 354 kcal, 73–77 g total carbohydrate, 10.6–12.1 g protein (including prolamins/hordeins), 2.3 g total fat, and 17 g total dietary fiber (including 4–8 g β-glucan depending on cultivar and processing). Micronutrients include niacin (B3) ~4.6 mg (29% DV), vitamin B6 ~0.32 mg (19% DV), iron ~2.5 mg (14% DV), zinc ~2.7 mg (25% DV), selenium ~37 μg (67% DV), manganese ~1.9 mg (83% DV), and copper ~0.5 mg (56% DV), with two-row varieties generally outperforming modern improved cultivars in these parameters. Phytochemicals include total phenolics 3.21–9.73 mg GAE/g DW, ferulic acid 104–365 μg/g (predominantly bound), p-coumaric acid 15–374 μg/g, prodelphinidin B3 90–197 μg/g, total tocols 38–44 μg/g (α-tocotrienol 17–20 μg/g dominant), 7-hydroxymatairesinol 541 μg/100g, and abscisic acid 7.37–235.46 ng/g. Bioavailability of bound phenolics is limited without colonic microbial fermentation; free phenolic forms (~5% of total) are absorbed in the small intestine, while tocols exhibit good bioavailability; pearling outer fractions concentrates phenolics and tocols but sacrifices fiber density.
How It Works
Mechanism of Action
The primary antioxidant mechanism involves phenolic acids (ferulic acid, p-coumaric acid) donating hydrogen atoms to neutralize free radicals and chelating Cu(II) and Fe(II) ions that catalyze lipid peroxidation, directly inhibiting LDL oxidation in a concentration-dependent manner. β-Glucans exert hypolipidemic effects by forming a viscous gel in the small intestinal lumen that sequesters bile acids and prevents their enterohepatic recirculation, compelling hepatocytes to upregulate CYP7A1-mediated de novo bile acid synthesis from cholesterol and thereby reducing circulating LDL-C. Tocols—principally α-tocotrienol and α-tocopherol—intercalate into cell membranes and lipoproteins, quenching lipid peroxyl radicals via single-electron transfer and regenerating via ascorbate-dependent reduction, while tocotrienols additionally suppress HMG-CoA reductase post-translationally through a mevalonate-independent pathway. Plant lignans undergo colonic biotransformation by Lachnospiraceae and Ruminococcaceae species to enterolignans that act as selective estrogen receptor modulators (SERMs) and inhibit nuclear factor-kappa B (NF-κB) transcriptional activity, reducing downstream expression of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α).
Clinical Evidence
Human clinical evidence directly attributable to two-row barley as a defined botanical intervention does not currently exist in peer-reviewed literature; the cultivar has not been isolated as a trial variable in registered RCTs. The most clinically actionable data is extrapolated from pooled barley β-glucan RCTs and meta-analyses, which demonstrate statistically significant LDL-C reductions of 5–7% (approximately 0.21–0.26 mmol/L) at β-glucan doses of 3–6 g/day across trials ranging from 4 to 12 weeks in duration, with higher confidence for cardiovascular endpoints. Glycemic outcomes from barley β-glucan interventions similarly show reductions in postprandial blood glucose area under the curve (AUC) of 20–30% versus control in short-term crossover studies, though long-term HbA1c data are lacking. Overall confidence in two-row barley-specific clinical outcomes is low-to-moderate; the in vitro phytochemical data are compelling and mechanistically coherent, but cultivar-specific human trials with adequately powered sample sizes are needed before definitive efficacy claims can be made.
Safety & Interactions
Two-row barley consumed as whole grain or flour at typical dietary amounts is considered safe for the general population and carries de facto GRAS (Generally Recognized as Safe) status in food applications; no upper tolerable intake level has been formally established for barley grain or its β-glucan fraction in healthy adults. Individuals with celiac disease or non-celiac gluten sensitivity must strictly avoid barley in all forms, as hordein prolamins (comprising 10–15% of total protein) trigger immune-mediated intestinal damage equivalent in severity to wheat gliadin exposure. High-dose β-glucan supplementation (above 6–10 g/day) may cause dose-dependent gastrointestinal discomfort including bloating, flatulence, and altered bowel transit, particularly in individuals unaccustomed to high-fiber diets or those with irritable bowel syndrome; gradual dose titration is recommended. No clinically significant drug interactions have been formally documented in peer-reviewed literature for two-row barley extracts specifically; however, the viscous fiber matrix may theoretically reduce absorption rate of co-administered oral medications (particularly narrow therapeutic index drugs) if taken simultaneously, suggesting a precautionary 1–2 hour separation; pregnant and lactating women may consume two-row barley as food without restriction, but concentrated β-glucan or phenolic supplements lack safety data for these populations.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Two-rowed barleyDa Mai (Traditional Chinese Medicine)Yava (Ayurveda)Hordeum vulgareMalting barleyAncient Two-Row Barley (Hordeum vulgare subsp. distichon)Hulled barley
Frequently Asked Questions
What makes two-row barley healthier than six-row barley?
Two-row barley generally contains higher starch content (70–80%), a more favorable phenolic acid profile, and superior micronutrient density including more niacin, vitamin B6, iron, zinc, selenium, manganese, and copper compared to six-row varieties. Its larger, more uniform kernel also concentrates bioactive compounds like β-glucans, ferulic acid (104–365 μg/g), and tocols (38–44 μg/g total) in proportions that are more consistent across harvests, making it a preferred choice for both malting and functional food applications.
How much two-row barley do I need to eat to lower cholesterol?
Meta-analyses of barley β-glucan interventions indicate that 3 g of β-glucan per day—achievable through approximately 75–100 g of whole-grain barley—reduces LDL cholesterol by approximately 5–7% over 4–12 weeks, consistent with the FDA-qualified health claim for barley β-glucan. For maximum effect, barley should be consumed as part of meals rather than in isolation, as the viscous β-glucan gel forms in the intestinal lumen and binds bile acids most effectively when food is present; higher doses of 6 g/day may produce modestly greater reductions.
Is two-row barley safe for people with gluten intolerance?
No—two-row barley contains hordein prolamins, which are gluten proteins structurally homologous to wheat gliadin and rye secalin; individuals with celiac disease will experience immune-mediated intestinal damage upon consumption, and those with non-celiac gluten sensitivity typically experience symptomatic reactions. Barley must be completely avoided in all forms—whole grain, flour, malt, barley water, and barley-derived supplements—by anyone diagnosed with celiac disease or confirmed gluten sensitivity, with no safe lower threshold established for these populations.
What are the main antioxidant compounds in two-row barley?
The primary antioxidant compounds in two-row barley are ferulic acid (104–365 μg/g, predominantly in bound form), p-coumaric acid (15–374 μg/g), prodelphinidin B3 (90–197 μg/g), procyanidin C2 (5–19 μg/g), α-tocotrienol (17–20 μg/g, approximately 48% of total tocols), and α-tocopherol (17.7–33.9% of tocols). These compounds work through complementary mechanisms—phenolics via hydrogen atom donation and metal chelation, tocols via lipid peroxyl radical quenching in membranes—producing total phenolic values of 3.21–9.73 mg GAE/g DW depending on cultivar and processing method.
What is the traditional preparation of barley water and what was it used for?
Traditional barley water is prepared by simmering 50–100 g of hulled two-row barley grains in 1–1.5 liters of water for 30–45 minutes, then straining off the grain and consuming the liquid warm or chilled, sometimes flavored with lemon juice or honey. Historically used since ancient Egyptian times and codified in British pharmacopoeias through the 19th century, barley water was prescribed for febrile illness, diarrhea, urinary tract irritation, and post-illness convalescence, with its soluble β-glucan and demulcent properties providing a physiologically plausible basis for these traditional indications.
What is the beta-glucan content in two-row barley compared to other grains?
Two-row barley contains 3–7% β-glucan by dry weight, making it one of the richest natural sources of this soluble fiber among cereal grains. This is significantly higher than wheat (0.5–1%) and comparable to oats (3–8%), which explains why barley is equally effective for cholesterol reduction in clinical studies. The β-glucan concentration varies by barley variety and growing conditions, with hull-less varieties typically containing higher levels than hulled varieties.
Can I get the cholesterol-lowering benefits of two-row barley from barley flour or barley extract supplements?
Yes, barley flour and β-glucan-enriched extracts retain the active compounds responsible for cholesterol reduction, though effectiveness depends on β-glucan retention during processing. Whole barley groats provide approximately 3–6 g of β-glucan per serving, while concentrated extracts may deliver therapeutic doses in smaller quantities. However, food-grade barley flour (which retains bran) is generally more effective than refined barley products, as processing can remove up to 50% of the soluble fiber content.
How does the bioavailability of two-row barley's antioxidants change when it is cooked or processed?
Cooking two-row barley increases the bioavailability of bound phenolic acids like ferulic acid by breaking down cell wall matrices and making compounds more accessible for absorption. However, prolonged boiling (>60 minutes) can leach some water-soluble antioxidants into cooking water, resulting in 15–30% loss if the liquid is discarded. Steaming or pressure-cooking preserves more antioxidant content while still improving digestibility compared to raw barley.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w two-row-barley-hordeum-vulgare curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
